Streetbeat News

Regulatory

SLS

SELLAS Life Sciences Group has received FDA Orphan Drug Designation for its Acute Myeloid Leukemia treatment. This designation provides certain benefits, including tax credits for clinical testing.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 3:49 pm

EIS

SPY

USO

President Biden is scheduled to deliver remarks on Israel at 1 p.m. ET, as reported by Fox Business Network. The content of the speech is not specified.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 3:33 pm

META

Meta Platforms, Inc (NASDAQ:META) is under scrutiny for its policies on manipulated content and AI-created 'deepfakes' after refusing to remove a misleading video of U.S. President Joe Biden from Facebook. The company's Oversight Board has initiated a review to assess the adequacy of Meta's guidelines on altered videos and images. The review aims to establish best practices for authenticating video content at scale, especially as AI-altered content becomes more advanced and prevalent.

Portfolio Pulse from Anusuya Lahiri

October 10, 2023 | 3:32 pm

EIS

SPY

USO

President Biden will not urge Israel to exercise restraint, according to officials. This could potentially impact the geopolitical landscape and indirectly affect the performance of certain ETFs.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 3:32 pm

CGC

Canopy Growth has received EU GMP certification for its cannabis cultivation facility in Kincardine, Ontario. This news has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 3:31 pm

CCL

CUK

EIS

RCL

Israel's Ministry of Tourism has advised against tours, suggesting that those arriving on cruises should stay on their ships and tourists should remain in their hotels. This could impact cruise companies and the Israeli ETF.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 3:27 pm

SPY

Raphael Bostic, the president of the Federal Reserve Bank of Atlanta, stated that the Federal Reserve is in the process of finding a new equilibrium on rates, according to Reuters.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:57 pm

SPY

Raphael Bostic, president of the Federal Reserve Bank of Atlanta, stated that there is no need to increase rates any further. However, he did not rule out the possibility of a rate increase if the economic outlook changes.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:56 pm

SPY

Federal Reserve Bank of Atlanta President Raphael Bostic stated that there is more to be done to achieve the 2% inflation target, but he believes that the current policy is in a good place to reach this goal. He also mentioned that he does not foresee a recession in his 'Dot Plot'.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:54 pm

SPY

Federal Reserve's Bostic has stated that inflation has improved considerably, but there is still a long way to go to reach the inflation target.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:52 pm